Results 41 to 50 of about 10,604,379 (306)

Association Between MIND Diet Adherence and Mortality: Insights from Diabetic and Non-Diabetic Cohorts

open access: yesNutrition & Diabetes, 2023
Background/Objectives To date, evidence regarding the protective roles of the Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet in patients with type 2 diabetes mellitus (T2DM) is scarce.
Yanjun Song   +7 more
doaj   +1 more source

Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis

open access: yesCardiovascular Diabetology, 2023
Background Emerging evidence suggests that remnant cholesterol (RC) is strongly associated with an increased incidence of cardiometabolic diseases (CMD). However, the causality have not been confirmed.
Baoyi Guan, Anlu Wang, Hao Xu
semanticscholar   +1 more source

Cardiometabolic diseases.

open access: yesRevista brasileira de epidemiologia = Brazilian journal of epidemiology, 2019
Cardiometabolic diseases are prevalent in populations and are among the leading causes of death. Objective: This sub-study of the Health, Well-being and Aging (SABE) study describes the self-reported prevalence of diabetes mellitus (DM), hypertension, and atherosclerotic cardiovascular disease (CVD) for its three waves (2000, 2006, and 2010).
Sandra Roberta Gouvea, Ferreira   +4 more
openaire   +2 more sources

Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis

open access: yesJournal of Clinical Medicine, 2023
Psoriasis is associated with cardiometabolic and cardiovascular diseases. Biologic therapy targeting tumor necrosis factor (TNF)-α, interleukin (IL)-23, and IL-17 may improve not only psoriasis but also cardiometabolic diseases.
T. Hagino   +3 more
semanticscholar   +1 more source

HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study

open access: yesCardiovascular Diabetology, 2023
Background Prediabetes is common and associated with poor prognosis in patients with acute coronary syndrome and those undergoing revascularization. However, the impact of prediabetes on prognosis in patients with coronary intermediate lesions remains ...
Chenxi Song   +17 more
doaj   +1 more source

The gut microbiota-bile acid axis links the positive association between chronic insomnia and cardiometabolic diseases

open access: yesNature Communications, 2022
Evidence from human cohorts indicates that chronic insomnia is associated with higher risk of cardiometabolic diseases (CMD), yet whether gut microbiota plays a role is unclear.
Zengliang Jiang   +18 more
semanticscholar   +1 more source

Amine oxidase copper-containing 3 (AOC3) inhibition: a potential novel target for the management of diabetic retinopathy

open access: yesInternational Journal of Retina and Vitreous, 2021
Background Diabetic retinopathy (DR), a microvascular complication of diabetes, is the leading cause of visual impairment in people aged 20–65 years and can go undetected until vision is irreversibly lost.
David S. Boyer   +5 more
doaj   +1 more source

Rationale and design of a randomized controlled trial: The effect of intensive lipid-lowering therapy with PCSK9 inhibitor on endothelial-coverage of stent strut after percutaneous coronary intervention (PCI) for patients with acute coronary syndrome (ACS): Optical coherence tomography (OCT) study (PIECES-OCT study)

open access: yesHeliyon, 2023
Background: For the patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) for at least 1 year is recommended in the guidelines to minimize the risk of stent thrombosis ...
Zheng Yin   +14 more
doaj   +1 more source

Vitamin D, Gut Microbiota, and Cardiometabolic Diseases—A Possible Three-Way Axis

open access: yesInternational Journal of Molecular Sciences, 2023
Metabolic syndrome (MetSyn) is a precursor for several cardiometabolic diseases such as obesity, type-2 diabetes mellitus (T2DM), and cardiovascular diseases.
Ayah Sukik, Joud Alalwani, Vijay Ganji
semanticscholar   +1 more source

Histone Deacetylases and Cardiometabolic Diseases [PDF]

open access: yesArteriosclerosis, Thrombosis, and Vascular Biology, 2015
Cardiometabolic disease, emerging as a worldwide epidemic, is a combination of metabolic derangements leading to type 2 diabetes mellitus and cardiovascular disease. Genetic and environmental factors are linked through epigenetic mechanisms to the pathogenesis of cardiometabolic disease.
Kan Hui, Yiew   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy